methylmalonic acid has been researched along with dacarbazine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drappatz, J; Hamilton, RL; Laymon, CM; Lieberman, FS; Mountz, JM; Oborski, MJ | 1 |
1 other study(ies) available for methylmalonic acid and dacarbazine
| Article | Year |
|---|---|
First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy.
Topics: Aged; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Dacarbazine; Glioblastoma; Humans; Male; Methylmalonic Acid; Positron-Emission Tomography; Temozolomide; Treatment Outcome | 2014 |